Bioradius Therapeutic Research Private Limited, a active private limited company, was established on 28 February 2018 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999PN2018PTC175042. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 36 professional, Its leadership includes Senthilmurugan Thyagarajan (Additional Director), Krishnaveni Gadiraju (Additional Director). Past directors included Kumara Chandrasekhara Varma Gadiraju, Ramamohana Raju Gadiraju. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sr No 234, 235 & 245 India Land Global Industrial Park, Hinjewadi Phase 1, Pune, Maharashtra, 411057.
U74999PN2018PTC175042
175042
28 February 2018
₹1.00 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Bioradius Therapeutic Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Senthilmurugan Thyagarajan | Additional Director | 18 Mar 2021 | Current |
| Krishnaveni Gadiraju | Additional Director | 18 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2021 | Past |
| Pramod Abcsdd | Director | 30 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bioradius Therapeutic Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.22% increase. The company also saw a substantial improvement in profitability, with a 166.66% increase in profit. The company's net worth Soared by an impressive increase of 31.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bioradius Therapeutic Research had a public holding of 81.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Bioradius Therapeutic Research has a workforce of 36 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bioradius Therapeutic Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioradius Therapeutic Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bioradius Therapeutic Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Bioradius Therapeutic Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Senthilmurugan Thyagarajan was appointed as a Additional Director was appointed as a Additional Director on 18 Mar 2021 & has been associated with this company since 4 years 8 months . was documented.
The activity Krishnaveni Gadiraju was appointed as a Additional Director was appointed as a Additional Director on 18 Mar 2021 & has been associated with this company since 4 years 8 months . was completed.
Progress on Bioradius Therapeutic Research Private Limited was registered on 28 Feb 2018 with Roc Pune & aged 7 years 9 months as per MCA records. was documented.
The CIN of Bioradius Therapeutic Research Private Limited is U74999PN2018PTC175042.
Bioradius Therapeutic Research Private Limited is headquartered at Sr No 234, 235 & 245 India Land Global Industrial Park, Hinjewadi Phase 1, Pune, Maharashtra, 411057.
Bioradius Therapeutic Research Private Limited was incorporated on 28 February 2018.
The current directors of Bioradius Therapeutic Research Private Limited are
The primary industry of Bioradius Therapeutic Research Private Limited is Professional, Scientific And Technical.
Bioradius Therapeutic Research Private Limited is unlisted.
The authorized capital of Bioradius Therapeutic Research Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Bioradius Therapeutic Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX